FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

732996003: implant (unité de présentation)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2017. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3498537011 Implant (unit of presentation) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3498538018 Implant en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
798881000241119 implant fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Common French translation module (core metadata concept)
798891000241117 implant (unité de présentation) fr Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT Common French translation module (core metadata concept)


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Implant (unit of presentation) est un(e) (attribut) Unit of presentation (unit of presentation) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Estradiol 100 mg prolonged-release subcutaneous implant Has presentation strength denominator unit (attribute) True Implant (unit of presentation) Inferred relationship Some 1
Estradiol 100 mg prolonged-release subcutaneous implant Has unit of presentation True Implant (unit of presentation) Inferred relationship Some
Product containing precisely ganciclovir 4.5 milligram/1 each prolonged-release ocular implant (clinical drug) Has unit of presentation True Implant (unit of presentation) Inferred relationship Some
Product containing precisely ganciclovir 4.5 milligram/1 each prolonged-release ocular implant (clinical drug) Has presentation strength denominator unit (attribute) True Implant (unit of presentation) Inferred relationship Some 1
Levonorgestrel 75 mg prolonged-release subcutaneous implant Has presentation strength denominator unit (attribute) True Implant (unit of presentation) Inferred relationship Some 1
Levonorgestrel 75 mg prolonged-release subcutaneous implant Has unit of presentation True Implant (unit of presentation) Inferred relationship Some
Testosterone 100 mg prolonged-release subcutaneous implant Has unit of presentation True Implant (unit of presentation) Inferred relationship Some
Testosterone 100 mg prolonged-release subcutaneous implant Has presentation strength denominator unit (attribute) True Implant (unit of presentation) Inferred relationship Some 1
Product containing precisely goserelin (as goserelin acetate) 10.8 milligram/1 each prolonged-release subcutaneous implant (clinical drug) Has unit of presentation True Implant (unit of presentation) Inferred relationship Some
Product containing precisely goserelin (as goserelin acetate) 10.8 milligram/1 each prolonged-release subcutaneous implant (clinical drug) Has presentation strength denominator unit (attribute) True Implant (unit of presentation) Inferred relationship Some 1
Testosterone 200 mg prolonged-release subcutaneous implant Has presentation strength denominator unit (attribute) True Implant (unit of presentation) Inferred relationship Some 1
Testosterone 200 mg prolonged-release subcutaneous implant Has unit of presentation True Implant (unit of presentation) Inferred relationship Some
Dexamethasone 700 microgram prolonged-release ocular implant Has presentation strength denominator unit (attribute) True Implant (unit of presentation) Inferred relationship Some 1
Dexamethasone 700 microgram prolonged-release ocular implant Has unit of presentation True Implant (unit of presentation) Inferred relationship Some
Product containing precisely goserelin (as goserelin acetate) 3.6 milligram/1 each prolonged-release subcutaneous implant (clinical drug) Has unit of presentation True Implant (unit of presentation) Inferred relationship Some
Product containing precisely goserelin (as goserelin acetate) 3.6 milligram/1 each prolonged-release subcutaneous implant (clinical drug) Has presentation strength denominator unit (attribute) True Implant (unit of presentation) Inferred relationship Some 1
Product containing precisely estradiol 25 milligram/1 each prolonged-release subcutaneous implant (clinical drug) Has unit of presentation True Implant (unit of presentation) Inferred relationship Some
Product containing precisely estradiol 25 milligram/1 each prolonged-release subcutaneous implant (clinical drug) Has presentation strength denominator unit (attribute) True Implant (unit of presentation) Inferred relationship Some 1
Product containing precisely estradiol 50 milligram/1 each prolonged-release subcutaneous implant (clinical drug) Has presentation strength denominator unit (attribute) True Implant (unit of presentation) Inferred relationship Some 1
Product containing precisely estradiol 50 milligram/1 each prolonged-release subcutaneous implant (clinical drug) Has unit of presentation True Implant (unit of presentation) Inferred relationship Some
Product containing precisely etonogestrel 68 milligram/1 each prolonged-release subcutaneous implant (clinical drug) Has unit of presentation True Implant (unit of presentation) Inferred relationship Some
Product containing precisely etonogestrel 68 milligram/1 each prolonged-release subcutaneous implant (clinical drug) Has presentation strength denominator unit (attribute) True Implant (unit of presentation) Inferred relationship Some 1
Product containing precisely fluocinolone acetonide 590 microgram/1 each prolonged-release ocular implant (clinical drug) Has presentation strength denominator unit (attribute) True Implant (unit of presentation) Inferred relationship Some 1
Product containing precisely fluocinolone acetonide 590 microgram/1 each prolonged-release ocular implant (clinical drug) Has unit of presentation True Implant (unit of presentation) Inferred relationship Some
Product containing precisely carmustine 7.7 milligram/1 each prolonged-release intralesional implant (clinical drug) Has unit of presentation True Implant (unit of presentation) Inferred relationship Some
Product containing precisely carmustine 7.7 milligram/1 each prolonged-release intralesional implant (clinical drug) Has presentation strength denominator unit (attribute) True Implant (unit of presentation) Inferred relationship Some 1

This concept is not in any reference sets

Back to Start